Novo Nordisk trumpets more Januvia-topping data for oral semaglutide
Just eight days after posting a trial win over Merck diabetes stalwart Januvia, Novo Nordisk candidate semaglutide is back with another....
FDA approves Epidiolex, the first marijuana-based pharmaceutical
On June 25th the FDA-approved Epidiolex (GW Pharmaceuticals plc), a cannabidiol (CBD) based drug to treat both Lennox-Gastaut and Dravet...
